Biotech stocks are experiencing substantial moves in pre-market activity on Monday, indicating potential trading opportunities.
By evaluating sentiment and momentum before the bell, pre-market analysis becomes a foundational step in any trader's pre-market routine.
In the Green - Pre-market Gainers
On Monday, the following stocks are trading significantly higher in the pre-market session.
1. Fulcrum Therapeutics Inc. (FULC) - up 52% at $13.502. Barinthus Biotherapeutics PLC - ADR. (BRNS) - up 25% at $0.903. Immix Biopharma Inc. (IMMX) - up 20% at $6.654. Arcellx Inc. (ACLX) - up 14% at $79.455. Ocular Therapeutix Inc. (OCUL) - up 13% at $14.206. HeartSciences Inc. (HSCS) - up 12% at $2.977. Kymera Therapeutics Inc. (KYMR) - up 11% at $73.888. Dyne Therapeutics Inc. (DYN) - up 11% at $22.509. Armata Pharmaceuticals Inc. (ARMP) - up 10% at $6.2010. ALX Oncology Holdings Inc. (ALXO) - up 9% at $1.55
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.